(Q41852319)

13 October 2017

title

Characteristics of the Principal Neutralizing Determinant of HIV-1 Prevalent in Japan (English)

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

8 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

8 November 2022

author name string

Hattori T

1

1 reference

13 October 2017

Shiozaki K

2

1 reference

13 October 2017

Eda Y

3

1 reference

13 October 2017

Tokiyoshi S

4

1 reference

13 October 2017

Matsushita S

5

1 reference

13 October 2017

Inaba H

6

1 reference

13 October 2017

Fujimaki M

7

1 reference

13 October 2017

Meguro T

8

1 reference

13 October 2017

Yamada K

9

1 reference

13 October 2017

Honda M

10

1 reference

13 October 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1720629

8 November 2022

publication date

1 October 1991

1 reference

full work available at URL

13 October 2017

http://www.liebertpub.com/doi/pdf/10.1089/aid.1991.7.825

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

AIDS Research and Human Retroviruses

8 November 2022

published in

1 reference

13 October 2017

volume

7

1 reference

13 October 2017

issue

10

1 reference

13 October 2017

page(s)

825-830

1 reference

Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of Japan

13 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Incubation period of AIDS in San Francisco

8 November 2022

3

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

8 November 2022

4

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

8 November 2022

5

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

8 November 2022

6

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex

8 November 2022

7

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

8 November 2022

8

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

8 November 2022

9

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

8 November 2022

10

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

8 November 2022

11

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

8 November 2022

12

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain

8 November 2022

13

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

8 November 2022

15

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Complete nucleotide sequence of the AIDS virus, HTLV-III

8 November 2022

16

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

8 November 2022

17

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Further developments of protein secondary structure prediction using information theory. New parameters and consideration of residue pairs

8 November 2022

19

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Triplet information in helix prediction applied to the analysis of super-secondary structures

8 November 2022

20

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Predicting the secondary structure of globular proteins using neural network models

8 November 2022

21

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Theory of protein secondary structure and algorithm of its prediction.

8 November 2022

22

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Amino acid sequence homology applied to the prediction of protein secondary structures, and joint prediction with existing methods

8 November 2022

23

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection

8 November 2022

25

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

A neutralizing epitope of human immunodeficiency virus type 1 has homologous amino acid sequences with the active site of inter-alpha-trypsin inhibitor

8 November 2022

26

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Structure of bovine pancreatic trypsin inhibitor. Results of joint neutron and X-ray refinement of crystal form II

8 November 2022

27

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

8 November 2022

β-turns in proteins

28

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

Crystal structure of the complex of porcine trypsin with soybean trypsin inhibitor (Kunitz) at 2.6 Å resolution

8 November 2022

29

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

8 November 2022

A chink in HIV's armour?

30

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

8 November 2022

31

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.825

8 November 2022

Identifiers

1 reference

13 October 2017

1 reference